• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米材料优化的治疗癌症骨转移溶骨性药物输送系统。

The optimized drug delivery systems of treating cancer bone metastatic osteolysis with nanomaterials.

机构信息

Department of Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.

State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, People's Republic of China.

出版信息

Drug Deliv. 2021 Dec;28(1):37-53. doi: 10.1080/10717544.2020.1856225.

DOI:10.1080/10717544.2020.1856225
PMID:33336610
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7751395/
Abstract

Some cancers such as human breast cancer, prostate cancer, and lung cancer easily metastasize to bone, leading to osteolysis and bone destruction accompanied by a complicated microenvironment. Systemic administration of bisphosphonates (BP) or denosumab is the routine therapy for osteolysis but with non-negligible side effects such as mandibular osteonecrosis and hypocalcemia. Thus, it is imperative to exploit optimized drug delivery systems, and some novel nanotechnology and nanomaterials have opened new horizons for scientists. Targeted and local drug delivery systems can optimize biodistribution depending on nanoparticles (NPs) or microspheres (MS) and implantable biomaterials with the controllable property. Drug delivery kinetics can be optimized by smart and sustained/local drug delivery systems for responsive delivery and sustained delivery. These delicately fabricated drug delivery systems with special matrix, structure, morphology, and modification can minimize unexpected toxicity caused by systemic delivery and achieve desired effects through integrating multiple drugs or multiple functions. This review summarized recent studies about optimized drug delivery systems for the treatment of cancer metastatic osteolysis, aimed at giving some inspiration in designing efficient multifunctional drug delivery systems.

摘要

一些癌症,如乳腺癌、前列腺癌和肺癌,很容易转移到骨骼,导致溶骨性和骨破坏,并伴有复杂的微环境。双膦酸盐(BP)或地舒单抗的全身给药是治疗溶骨性疾病的常规疗法,但存在不可忽视的副作用,如下颌骨坏死和低钙血症。因此,迫切需要开发优化的药物递送系统,一些新的纳米技术和纳米材料为科学家们开辟了新的视野。基于纳米颗粒(NPs)或微球(MS)和可植入生物材料的靶向和局部药物递送系统可以根据其可控特性优化生物分布。通过智能和持续/局部药物递送系统优化药物递送动力学,以实现响应性和持续递送。这些精心设计的药物递送系统具有特殊的基质、结构、形态和修饰,可以最大限度地减少全身给药引起的意外毒性,并通过整合多种药物或多种功能来达到预期的效果。本综述总结了最近关于治疗癌症转移性溶骨性疾病的优化药物递送系统的研究,旨在为设计高效多功能药物递送系统提供一些启示。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be9/7751395/4babc72a9e10/IDRD_A_1856225_F0007_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be9/7751395/90879bc1f9fa/IDRD_A_1856225_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be9/7751395/929777b92701/IDRD_A_1856225_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be9/7751395/4ec3e9d903bb/IDRD_A_1856225_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be9/7751395/ec98a0694622/IDRD_A_1856225_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be9/7751395/06c3ce153d0d/IDRD_A_1856225_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be9/7751395/ddf675c22be0/IDRD_A_1856225_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be9/7751395/4babc72a9e10/IDRD_A_1856225_F0007_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be9/7751395/90879bc1f9fa/IDRD_A_1856225_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be9/7751395/929777b92701/IDRD_A_1856225_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be9/7751395/4ec3e9d903bb/IDRD_A_1856225_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be9/7751395/ec98a0694622/IDRD_A_1856225_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be9/7751395/06c3ce153d0d/IDRD_A_1856225_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be9/7751395/ddf675c22be0/IDRD_A_1856225_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be9/7751395/4babc72a9e10/IDRD_A_1856225_F0007_C.jpg

相似文献

1
The optimized drug delivery systems of treating cancer bone metastatic osteolysis with nanomaterials.纳米材料优化的治疗癌症骨转移溶骨性药物输送系统。
Drug Deliv. 2021 Dec;28(1):37-53. doi: 10.1080/10717544.2020.1856225.
2
Preclinical evaluation of zoledronate using an in vitro mimetic cellular model for breast cancer metastatic bone disease.使用乳腺癌转移性骨病的体外模拟细胞模型对唑来膦酸进行临床前评估。
Biochim Biophys Acta. 2013 Jun;1830(6):3625-34. doi: 10.1016/j.bbagen.2013.01.020. Epub 2013 Feb 5.
3
Pamidronate functionalized nanoconjugates for targeted therapy of focal skeletal malignant osteolysis.用于局灶性骨骼恶性骨溶解靶向治疗的帕米膦酸盐功能化纳米共轭物。
Proc Natl Acad Sci U S A. 2016 Aug 9;113(32):E4601-9. doi: 10.1073/pnas.1603316113. Epub 2016 Jul 25.
4
Mechanisms of action of bisphosphonates on tumor cells and prospects for use in the treatment of malignant osteolysis.双膦酸盐对肿瘤细胞的作用机制及在恶性骨溶解治疗中的应用前景
Joint Bone Spine. 2000 Jan;67(1):22-9.
5
Bisphosphonates as treatment of bone metastases.双膦酸盐类药物治疗骨转移。
Curr Pharm Des. 2010;16(11):1262-71. doi: 10.2174/138161210791034003.
6
Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis.NFκB/β-连环蛋白轴对乳腺癌相关骨溶解的骨自主性贡献的药理学证据。
Cancer Lett. 2017 Dec 1;410:180-190. doi: 10.1016/j.canlet.2017.09.034. Epub 2017 Sep 28.
7
Engineered Multifunctional Nanomedicine for Simultaneous Stereotactic Chemotherapy and Inhibited Osteolysis in an Orthotopic Model of Bone Metastasis.工程化多功能纳米药物在骨转移的原位模型中同时进行立体定向化疗和抑制溶骨性骨破坏。
Adv Mater. 2017 Apr;29(13). doi: 10.1002/adma.201605754. Epub 2017 Jan 30.
8
Bisphosphonates and metastatic bone disease.双膦酸盐与转移性骨病
Ann Oncol. 2006 Mar;17 Suppl 2:ii91-95. doi: 10.1093/annonc/mdj935.
9
Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.白花丹素通过调节肿瘤-骨微环境抑制乳腺癌骨转移和骨溶解。
Curr Mol Med. 2012 Sep;12(8):967-81. doi: 10.2174/156652412802480871.
10
Metal-Organic Framework Nanoparticles for Ameliorating Breast Cancer-Associated Osteolysis.金属有机骨架纳米粒子在改善乳腺癌相关性骨溶解中的作用。
Nano Lett. 2020 Feb 12;20(2):829-840. doi: 10.1021/acs.nanolett.9b02916. Epub 2020 Jan 14.

引用本文的文献

1
Transforming bone cancer treatment: a comprehensive review of green-synthesized metal nanoparticles.变革性骨癌治疗:绿色合成金属纳米粒子的综合综述
Cancer Cell Int. 2025 May 25;25(1):193. doi: 10.1186/s12935-025-03827-6.
2
Identification of CKAP2 as a Potential Target for Prevention of Gastric Cancer Progression: A Multi-Omics Study.鉴定CKAP2作为预防胃癌进展的潜在靶点:一项多组学研究
Int J Mol Sci. 2025 Feb 12;26(4):1557. doi: 10.3390/ijms26041557.
3
Bibliometric analysis of bone metastases from lung cancer research from 2004 to 2023.

本文引用的文献

1
Bioinspired Nanoparticles Engineered for Enhanced Delivery to the Bone.为增强向骨骼递送而设计的仿生纳米颗粒。
ACS Appl Nano Mater. 2019 Oct 25;2(10):6249-6257. doi: 10.1021/acsanm.9b01226. Epub 2019 Sep 17.
2
Development of Zoledronic Acid-Based Nanoassemblies for Bone-Targeted Anticancer Therapy.用于骨靶向抗癌治疗的基于唑来膦酸的纳米组装体的研发
ACS Biomater Sci Eng. 2019 May 13;5(5):2343-2354. doi: 10.1021/acsbiomaterials.9b00362. Epub 2019 Apr 8.
3
Ca, pH and thermo triple-responsive mechanized Zr-based MOFs for on-command drug release in bone diseases.
2004年至2023年肺癌骨转移研究的文献计量分析。
Front Oncol. 2024 Aug 6;14:1439209. doi: 10.3389/fonc.2024.1439209. eCollection 2024.
4
What enlightenment has the development of lung cancer bone metastasis brought in the last 22 years.在过去的22年里,肺癌骨转移的发展带来了哪些启示?
World J Clin Oncol. 2024 Jun 24;15(6):765-782. doi: 10.5306/wjco.v15.i6.765.
5
Luminescent Alendronic Acid-Conjugated Micellar Nanostructures for Potential Application in the Bone-Targeted Delivery of Cholecalciferol.基于阿仑膦酸的发光胶束纳米结构用于潜在的骨靶向递送胆钙化醇
Molecules. 2024 May 17;29(10):2367. doi: 10.3390/molecules29102367.
6
Nanoparticles for the Treatment of Bone Metastasis in Breast Cancer: Recent Advances and Challenges.用于治疗乳腺癌骨转移的纳米粒子:最新进展与挑战。
Int J Nanomedicine. 2024 Feb 23;19:1867-1886. doi: 10.2147/IJN.S442768. eCollection 2024.
7
Cytotoxicity Enhancement in Osteosarcoma with Multifunctional I-131 Radiotherapeutic Nanoparticles: In Vitro Three-Dimensional Spheroid Model and Release Kinetics Modeling.多功能 I-131 放射治疗纳米粒子增强骨肉瘤的细胞毒性:体外三维球体模型和释放动力学建模。
Molecules. 2024 Jan 29;29(3):630. doi: 10.3390/molecules29030630.
8
Regulation of the antibiotic elution profile from tricalcium phosphate bone cement by addition of bioactive glass.添加生物活性玻璃调节磷酸三钙骨水泥的抗生素洗脱曲线。
Sci Rep. 2024 Feb 2;14(1):2804. doi: 10.1038/s41598-024-53319-2.
9
Hierarchical Hybrid Coatings with Drug-Eluting Capacity for Mg Alloy Biomaterials.具有药物洗脱能力的镁合金生物材料分层混合涂层
Materials (Basel). 2023 Dec 18;16(24):7688. doi: 10.3390/ma16247688.
10
Single-cell and bulk RNA-sequencing analysis to predict the role and clinical value of CD36 in lung squamous cell carcinoma.单细胞和批量RNA测序分析以预测CD36在肺鳞状细胞癌中的作用和临床价值。
Heliyon. 2023 Nov 10;9(11):e22201. doi: 10.1016/j.heliyon.2023.e22201. eCollection 2023 Nov.
用于骨疾病中按需药物释放的钙、pH值和温度三重响应机械化锆基金属有机框架材料。
J Mater Chem B. 2016 Jan 7;4(1):135-140. doi: 10.1039/c5tb01789k. Epub 2015 Dec 2.
4
Alendronate/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer.阿仑膦酸钠/叶酸修饰的聚合物纳米粒用于针对骨转移乳腺癌的分级靶向化疗。
J Mater Chem B. 2020 May 6;8(17):3789-3800. doi: 10.1039/d0tb00046a.
5
RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies.基于RANKL/RANK系统的乳腺癌骨转移机制及相关治疗策略
Front Cell Dev Biol. 2020 Feb 11;8:76. doi: 10.3389/fcell.2020.00076. eCollection 2020.
6
Quercetin inhibits macrophage polarization through the p-38α/β signalling pathway and regulates OPG/RANKL balance in a mouse skull model.槲皮素通过 p-38α/β 信号通路抑制巨噬细胞极化,并调节小鼠颅骨模型中的 OPG/RANKL 平衡。
J Cell Mol Med. 2020 Mar;24(5):3203-3216. doi: 10.1111/jcmm.14995. Epub 2020 Feb 13.
7
Tuning Ligand Density To Optimize Pharmacokinetics of Targeted Nanoparticles for Dual Protection against Tumor-Induced Bone Destruction.调整配体密度以优化靶向纳米粒子的药代动力学,实现双重保护,防止肿瘤诱导的骨破坏。
ACS Nano. 2020 Jan 28;14(1):311-327. doi: 10.1021/acsnano.9b04571. Epub 2020 Jan 8.
8
Bone Metastasis: Current State of Play.骨转移:当前进展状况
Transl Oncol. 2020 Feb;13(2):308-320. doi: 10.1016/j.tranon.2019.10.012. Epub 2019 Dec 23.
9
Curcumin has immunomodulatory effects on RANKL-stimulated osteoclastogenesis in vitro and titanium nanoparticle-induced bone loss in vivo.姜黄素对体外 RANKL 刺激的破骨细胞生成和体内钛纳米颗粒诱导的骨丢失具有免疫调节作用。
J Cell Mol Med. 2020 Jan;24(2):1553-1567. doi: 10.1111/jcmm.14842. Epub 2019 Dec 17.
10
Engineering a Biodegradable Multifunctional Antibacterial Bioactive Nanosystem for Enhancing Tumor Photothermo-Chemotherapy and Bone Regeneration.工程化可生物降解多功能抗菌生物活性纳米系统,增强肿瘤光热-化学治疗和骨再生。
ACS Nano. 2020 Jan 28;14(1):442-453. doi: 10.1021/acsnano.9b06145. Epub 2019 Dec 24.